Investors

A leading Australian biotech advancing breakthrough therapies through science, strategy, and sustainable long-term value creation.

The Company offers investors exposure to high-growth opportunities in biotechnology and medical innovation. Our strategic research partnerships, robust research data portfolio, and commitment to evidence-based development position us to deliver sustainable returns and real-world medical impact.

Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim. Donec pede justo, fringilla vel, aliquet nec, vulputate eget, arcu. In enim justo, rhoncus ut, imperdiet a, venenatis vitae, justo.

2024 Annual Report

View the Annual Report to Shareholders 2024 here, or see historical reports in the table below.

ASX Announcements

[Weblinks table placed here]

View all

Share Price

[Weblinks chart placed here if included in Weblinks services package]

Prospectus

Financial Reports

Presentations

Media

Shareholder Information

The Company is listed on the Australian Securities Exchange (ASX:XXX).

Our Share Registry is managed by [share registry name].

Further information about management of share registry services or contacts for investor related enquiries. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim. Donec pede justo, fringilla vel, aliquet nec, vulputate eget, arcu. In enim justo, rhoncus ut, imperdiet a, venenatis vitae, justo.

Nullam dictum felis eu pede mollis pretium. Integer tincidunt. Cras dapibus. Vivamus elementum semper nisi. Aenean vulputate eleifend tellus. Aenean leo ligula, porttitor eu, consequat vitae, eleifend ac, enim.